Our capture technology lies on the use of a microdevice conceived for the physical trapping of circulating cancer-associated cells in physiological conditions. Manufactured using cutting-edge micro/nanotechnologies, its design was developed and optimized to ensure a selective capture of circulating cancer-associated cells using low-pressure conditions and with no pre-processing of the blood sample required to preserve the information these biomarkers contain.
Capture based on physical traits only
Capture of CTCs at different differenciation stages
Possible capture of clusters
Low contamination rate
Cell integrity preserved